financetom
Business
financetom
/
Business
/
Form 8.3 - Dalata Hotel Group plc
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3 - Dalata Hotel Group plc
Oct 24, 2025 5:24 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

(a) Full name of discloser

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Dalata Hotel Group plc ( DLTTF )

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

23-10-2025

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security
(Note 3)

€0.01 ordinary shares

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

0

0

0

0

(2) Cash-settled derivatives

6,731,375

3.18

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0

0

0

Total

6,731,375

3.18

0

0

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant
security

Purchase/sale

Number of
securities

Price per unit
(Note 5)

 

 

 

 

 

(b) Cash-settled derivative transactions

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

€0.01 ordinary shares

Equity Swap

Increasing a long position

87,992

6.43

€0.01 ordinary shares

Equity Swap

Increasing a long position

27,246

6.44

€0.01 ordinary shares

Equity Swap

Decreasing a long position

109,385

6.43

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

(c) Attachments

Is a Supplemental Form 8 attached?

NO

Class of relevant security
(Note 3)

€0.01 ordinary shares

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

0

0

0

0

(2) Cash-settled derivatives

6,731,375

3.18

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0

0

0

Total

6,731,375

3.18

0

0

0

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Source: Qube Research & Technologies LTD

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rogers Gets Competition Bureau Clearance for Maple Leaf Sports & Entertainment Deal
Rogers Gets Competition Bureau Clearance for Maple Leaf Sports & Entertainment Deal
Dec 13, 2024
05:01 PM EST, 12/13/2024 (MT Newswires) -- Rogers Communications (RCI-B.TO, RCI) after trade Friday said it received approval from the Competition Bureau to move forward with acquiring BCE's (BCE..TO) 37.5% stake in Maple Leaf Sports & Entertainment (MLSE), which owns the Toronto Maple Leafs hockey club, the Toronto Blue Jays baseball team and the Toronto Raptors basketball franchise. The Bureau...
Judge clears way for Musk appeal to try to restore $56 billion Tesla pay
Judge clears way for Musk appeal to try to restore $56 billion Tesla pay
Dec 13, 2024
WILMINGTON, Delaware (Reuters) - A Delaware judge cleared the way on Friday for Elon Musk and Tesla to begin legal appeals to try to reinstate the chief executive's record-breaking $56 billion pay package from the electric carmaker. The order by Chancellor Kathaleen McCormick of the Court of Chancery opens the 30-day window for an appeal to the Delaware Supreme Court....
Rogers Communications Gets Clearance for Maple Leaf Sports Stake Buy From Canada's Competition Bureau
Rogers Communications Gets Clearance for Maple Leaf Sports Stake Buy From Canada's Competition Bureau
Dec 13, 2024
05:03 PM EST, 12/13/2024 (MT Newswires) -- Rogers Communications ( RCIAF ) said late Friday that Canada's Competition Bureau has cleared its acquisition of Bell's 37.5% stake in Maple Leaf Sports & Entertainment. The agency issued a no-action letter on Thursday, which indicates that the Commissioner of Competition does not intend to challenge the deal. The deal is still subject...
Healthequity Insider Sold Shares Worth $2,417,900, According to a Recent SEC Filing
Healthequity Insider Sold Shares Worth $2,417,900, According to a Recent SEC Filing
Dec 13, 2024
05:05 PM EST, 12/13/2024 (MT Newswires) -- Stuart B. Parker, Director, on December 12, 2024, sold 25,000 shares in Healthequity ( HQY ) for $2,417,900. Following the Form 4 filing with the SEC, Parker has control over a total of 19,061 shares of the company, with 19,061 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1428336/000141588924029330/xslF345X05/form4-12132024_091227.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved